SE439484B - Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan - Google Patents

Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan

Info

Publication number
SE439484B
SE439484B SE7702129A SE7702129A SE439484B SE 439484 B SE439484 B SE 439484B SE 7702129 A SE7702129 A SE 7702129A SE 7702129 A SE7702129 A SE 7702129A SE 439484 B SE439484 B SE 439484B
Authority
SE
Sweden
Prior art keywords
substancing
mercaptoacyl
procedure
preparation
effects
Prior art date
Application number
SE7702129A
Other languages
English (en)
Swedish (sv)
Other versions
SE7702129L (sv
Inventor
T Fujita
M Oya
H Takashina
T Iso
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SE7702129L publication Critical patent/SE7702129L/xx
Publication of SE439484B publication Critical patent/SE439484B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7702129A 1976-03-08 1977-02-25 Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan SE439484B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2545576A JPS535112A (en) 1976-03-08 1976-03-08 New cysteine derivatives

Publications (2)

Publication Number Publication Date
SE7702129L SE7702129L (sv) 1977-09-09
SE439484B true SE439484B (sv) 1985-06-17

Family

ID=12166492

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702129A SE439484B (sv) 1976-03-08 1977-02-25 Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan

Country Status (8)

Country Link
US (2) US4305958A (jp)
JP (1) JPS535112A (jp)
CA (1) CA1079299A (jp)
CH (1) CH630069A5 (jp)
DE (1) DE2709820C2 (jp)
FR (1) FR2344533A1 (jp)
GB (1) GB1530071A (jp)
SE (1) SE439484B (jp)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339600A (en) * 1976-05-10 1982-07-13 E. R. Squibb & Sons, Inc. Compounds for alleviating angiotensin related hypertension
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
JPS6058908B2 (ja) * 1978-10-11 1985-12-23 参天製薬株式会社 システイン誘導体
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
JPS5756454A (en) * 1980-09-20 1982-04-05 Santen Pharmaceut Co Ltd Disulfide type cysteine derivative
JPS57142962A (en) * 1981-02-28 1982-09-03 Santen Pharmaceut Co Ltd Cyclodextrin clathrate compound of sulfur-containing compound
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
FR2563218B1 (fr) * 1984-04-19 1986-06-20 Synthelabo Derives d'acide n-((chloro-2 phenyl)methylthio-3 oxo-1 propyl)-aminoacetique substitue en a, leur preparation et leur application en therapeutique
EP0161172A1 (fr) * 1984-04-19 1985-11-13 Synthelabo Dérivés d'acide n-(phenylmethylthio-3 oxo-1 propyl)-aminoacétique, leur préparation et leur application en thérapeutique
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US5292926A (en) * 1988-01-25 1994-03-08 Santen Pharmaceutical Co., Ltd. Cysteine derivatives
ATE84303T1 (de) * 1988-01-25 1993-01-15 Santen Pharmaceutical Co Ltd Cysteinderivate.
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
JPH0449489U (jp) * 1990-08-31 1992-04-27
JP2814033B2 (ja) * 1992-01-10 1998-10-22 参天製薬株式会社 シスチン尿症治療剤
US6025393A (en) * 1995-09-25 2000-02-15 Santen Pharmaceutical Co., Ltd. Method for treatment of inflammatory intestinal diseases
US5670545A (en) * 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
WO2000033895A1 (en) 1998-12-07 2000-06-15 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
CN1312149C (zh) * 2002-12-23 2007-04-25 史宝珠 合成Bucillamine的中间体 5，5－二甲基－2－硫酮－4－酮－1－硫－3－氧－杂戊环
FR2868420B1 (fr) * 2004-04-06 2006-06-16 Oreal Utilisation de dimercaptoamides pour la deformation permanente des fibres keratiniques
US7875268B2 (en) * 2004-04-06 2011-01-25 L'oreal S.A. Dimercaptoamides, compositions comprising them as reducing agents, and processes for permanently reshaping keratin fibers therewith
CN101260101B (zh) * 2007-03-09 2010-05-26 上海信联化学制药有限公司 合成布溪那明的新中间体5,5-二甲基-1,3-酮-2,4-硫-杂戊环
CN103196729A (zh) * 2013-04-10 2013-07-10 吴鹏 用于处理粘液的试剂
WO2022153101A1 (en) 2021-01-12 2022-07-21 Optimus Drugs Private Limited Crystalline form i of bucillamine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2430455A (en) * 1944-11-20 1947-11-11 Parke Davis & Co Reaction products of s-benzyl penicillamines and g-penaldates and process for making same
US2900375A (en) * 1955-12-23 1959-08-18 Roussel Uclaf Method of making glutathione
CH451186A (de) * 1961-11-02 1968-05-15 Santen Phamarceutical Co Ltd Verfahren zur Herstellung von N-Mercaptopropionylglycin und dessen Derivaten
FR1491204A (fr) * 1962-08-10 1967-08-11 Santen Pharmaceutical Co Ltd Procédés pour la préparation des alpha-et beta mercaptopropionylglycocolle et de leurs dérivés
US3647834A (en) * 1969-08-11 1972-03-07 Mead Johnson & Co Zinc mercaptide n-acetylcysteine carboxylate salts
US3634365A (en) * 1969-08-27 1972-01-11 Dow Chemical Co Polymers of l-amino acid derivatives of s-(substituted benzyl) compounds
DE2132862A1 (de) * 1971-06-29 1973-01-18 Klosa Josef Dipl Chem Dr Rer N Mittel zur beseitigung von mundund koerpergeruechen
CA1009252A (en) * 1972-10-03 1977-04-26 Santen Pharmaceutical Co. N-(mercaptoacyl) aminoacids
DE2627069A1 (de) * 1975-06-19 1977-01-20 Ajinomoto Kk Verfahren zur herstellung von substituierten schwefelhaltigen l-aminosaeuren
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension

Also Published As

Publication number Publication date
FR2344533B1 (jp) 1980-06-27
FR2344533A1 (fr) 1977-10-14
JPS535112A (en) 1978-01-18
US4305958A (en) 1981-12-15
SE7702129L (sv) 1977-09-09
DE2709820C2 (de) 1982-07-29
CA1079299A (en) 1980-06-10
GB1530071A (en) 1978-10-25
CH630069A5 (de) 1982-05-28
JPS565388B2 (jp) 1981-02-04
US4137420A (en) 1979-01-30
DE2709820A1 (de) 1977-09-15

Similar Documents

Publication Publication Date Title
SE439484B (sv) Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan
SE7606224L (sv) Forfarande for framstellning av heterocykliska acylaminoderivat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
FI773738A (fi) Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE7701379L (sv) Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan
DK243276A (da) Acylaminoderivater
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE7707407L (sv) Forfarande for framstellning av cefamderivat
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE436744B (sv) Forfarande for framstellning av prostacyklinderivat
RO77308A (ro) Procedeu pentru prepararea derivatiilor aminochinazolinei substituite
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
RO75224A (ro) Procedeu pentru prepararea etilaminoditiocarbamatilor n-substituiti
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
DK243376A (da) Acylaminoderivater
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7702129-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7702129-3

Format of ref document f/p: F